Table 1.
Molecules in network | Focus molecules | Top diseases and functions | p–Value |
---|---|---|---|
31 |
Post–translational modification | (1.49E–09 – 4.73E–03) | |
Nervous system development and function | (1.16E–05 – 4.90E–02) | ||
Neurological disease | (1.16E–05 – 4.70E–02) | ||
31 |
Cardiac Inflammation | (8.27E–06 – 5.24E–01) | |
Cardiovascular disease | (8.27E–06 – 5.32E–01) | ||
Inflammatory disease | (8.27E–06 – 2.23E–01) | ||
28 |
Lipid metabolism | (4.27E–07 – 4.62E–02) | |
Molecular transport | (4.27E–07 – 4.62E–02) | ||
Small molecule biochemistry | (4.60E–06 – 4.73E–02) | ||
27 |
Embryonic development | (4.00E–05 – 1.95E–01) | |
Nervous system development and Function | (4.00E–05 – 2.62E–02) | ||
Organ development | (4.00E–05 – 4.01E–01) | ||
26 |
Cell morphology | (4.16E–04 – 4.26E–02) | |
Cellular assembly and organization, | (4.16E–04 – 4.72E–02) | ||
Hereditary disorder | (5.61E–04 – 1.05E–02) |